Cibus, Inc. announced significant advancements in its gene editing technology, particularly the establishment of production standards for its proprietary RTDS gene editing system, which enables the ...

The world stands on the edge of an era when gene editing can address many serious ills plaguing humankind, according to a pioneer of the revolutionary gene editing technique known as CRISPR-Cas9. But ...

Alternative splicing is a genetic process where different segments of genes are removed, and the remaining pieces are joined together during transcription to messenger RNA (mRNA). This mechanism ...

Alternative splicing is a genetic process where different segments of genes are removed, and the remaining pieces are joined together during transcription to messenger RNA (mRNA). This mechanism ...

The FDA has outlined a process for allowing a single application to cover multiple variants of a gene therapy. At the same ...

With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...

Alternative splicing is a genetic process where different segments of genes are removed, and the remaining pieces are joined together during transcription to messenger RNA (mRNA). This mechanism ...

Blood stem cells with driver mutations may be more likely to survive during clonal expansion. Some of these driver mutations have been linked with cancer in other settings. Gene therapy has the ...

The manufacturing question over adeno-associated viruses (AAV) for gene therapies has moved beyond whether a product can be made to whether it can be made consistently. That’s according to Forge ...

Alternative splicing is a genetic process where different segments of genes are removed, and the remaining pieces are joined together during transcription to messenger RNA (mRNA). This mechanism ...